Fri 25'th May 2018
ImmunoGen Stock Analysis
Technical stock analysis for Fri 25'th May 2018
ImmunoGen fell by -1.42% in the last day from $10.58 to $10.43 The price has been going up and down for this period, and there has been a -1.7% loss for the last 2 weeks. Volume has increased in the last day by 0.59 million shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 1.46 million shares bought and sold for approximately $15.21 million.
|Shorts||5.58% ( 2018-04-30 )|
ImmunoGen lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.86% during the next 3 months and, with 90% probability hold a price between $8.26 and $10.86 at the end of this period.
There are few to none technical positive signals at the moment. ImmunoGen holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $10.48 and $10.46. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday May 24, 2018, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSI14 is 54 and the stock is currently not being overbought or oversold
Support & Resistance
ImmunoGen finds support from accumulated volume at $10.32.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.37 (3.64%) between high and low. For the last week, the stock has had a daily average volatility of 3.90%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
ImmunoGen holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
Trade IMGN CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder